The Latin American COVID-19 diagnostics market will see a decline in CAGR of 19.5% during the forecast period. As Latin American countries are significantly expanding their testing capacity every month, the demand for RT-PCR testing has been emerging across these countries. For instance, on 6th May 2020, the Brazilian Health Ministry declared a national testing plan to curb and combat the COVID-19 pandemic. It had declared the target of buying 46 million tests. The program comprises dubbed Confirma COVID-19, which includes the lab test, referred to as RT-PCR. The objective is to buy a total of 24 million RT-PCR tests, suitable for people running symptoms until the eighth day since the infection.
Browse the full report description Latin America COVID-19 diagnostics Market Size, Share & Trends Analysis Report by Type (Instruments, Reagents & Kits, and Laboratory Testing Services), by Technology Type (PCR Test, Antigen Test, Serology Test, and Rapid/ PoC Test), by Sample Type (Oropharyngeal & Nasopharyngeal Swabs, Blood, Urine, Saliva, and Others), and by End-Users (Laboratories, Hospitals, Diagnostic Centers & Clinics, and Research Institutes) and Forecast, 2020-2026 at https://www.omrglobal.com/industry-reports/latin-america-covid-19-diagnostics-market
Additionally, the launch of new antigen tests may offer an opportunity for the increasing adoption of antigen tests in the country. Antigen tests can detect the presence of viral proteins in a biological sample, including saliva or tissue swabbed from the nasal cavity. These tests are normally cost-effective and provide results in minutes, as well as reveals an active infection. The antigen test that is available in Brazil includes QuickProfile COVID-19 Antigen Test, offered by Lumiquick Diagnostics, Inc. It is a method of the target antigen (or antibody) capture in samples with the use of a specific antibody (or antigen), and target molecule detection/quantitation using an enzyme reaction with its substrate. Emerging shift towards faster detection of COVID-19 and increasing focus of biotechnology companies and research institutes towards the development of more accurate and faster tests, is creating possibilities for the launch of new COVID-19 tests, including antigen test, in Latin American countries.
Market Coverage
|
Report Elements |
Details |
|
Study Period |
2020-2026 |
|
Segments Covered |
By Type, By Technology Type, By Sample Type, and By End-Users |
|
Countries Covered |
Brazil, Argentina, Colombia, Mexico, Chile, and Rest of Latin America |
|
Key Companies Profiled |
Biolinker Synthetic
Biology, Biologix Group Ltd., Hi Technologies, and Diagnos Med srl |
Key questions addressed by the report
o Recovery Timeline
o Deviation from pre-COVID
o Most affected region/segment
o Recommendations
Latin American COVID-19 Diagnostics Market – Segmentation
By Type
By Technology Type
o Chromatographic Immunoassay
o Fluorescent Immunoassay
o Chemiluminescent Immunoassay
o Enzyme-Linked Immunosorbent Assay (ELISA)
o Neutralization
o Chemiluminescent Immunoassay
By Sample Type
By End-Users
Latin American COVID-19 Diagnostics Market – Segmentation by Geography
To learn more about this report request a free sample copy
@ https://www.omrglobal.com/request-sample/latin-america-covid-19-diagnostics-market